Anti-IGF-1R antibodies and uses thereof
View Patent ↗The invention relates to antibodies which bind to insulin like growth factor receptor-1 (IGF-1R) and uses thereof, in particular in the diagnosis and treatment of cancer. Specific human and murine monoclonal antibodies which inhibit IGF-1R-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific human and murine monoclonal antibodies which block the ability of the ligands, insulin like growth factor 1 (IGF-1) and insulin like growth factor 2 (IGF-2) to bind to IGF-1R, as well as fragments, variants and derivatives of such antibodies. The invention also includes polynucleotides encoding the above antibodies or fragments, variants or derivatives thereof, as well as vectors and host cells comprising such polynucleotides. The invention further includes methods of diagnosing and treating cancer using antibodies of the invention.
1. An isolated antibody or antigen-binding fragment thereof wherein said antibody is M13-C06.G4.P.agly or a fragment thereof which specifically binds to IGF-1R produced by Chinese Hamster Ovary (CHO) cells deposited under American Type Culture Collection (ATCC) Deposit Number PTA-7444.
2. An isolated antibody or antigen-binding fragment thereof, wherein said antibody or fragment thereof comprises an antigen binding domain identical to that of a monoclonal Fab antibody fragment of M13-C06.G4.P.agly produced by Chinese Hamster Ovary (CHO) cells deposited under American Type Culture Collection (ATCC) Deposit Number PTA-7444.
3. An isolated antibody or fragment thereof which specifically binds to IGF-1R, wherein the VH of said antibody or fragment thereof comprises the amino acid sequence of SEQ ID NO: 14.
4. An isolated antibody or fragment thereof which specifically binds to IGF-1R, wherein the VL of said antibody or fragment thereof comprises the amino acid sequence of SEQ ID NO: 78.
5. An isolated antibody or fragment thereof which specifically binds to IGF-1R, wherein the VH and VL of said antibody or fragment thereof comprise, respectively, the amino acid sequences of SEQ ID NO: 14 and SEQ ID NO: 78.
6. An isolated antibody or fragment thereof which specifically binds to IGF-1R, wherein the VH of said antibody or fragment thereof comprises the VH-CDR1, VH-CDR2, and VH-CDR3 amino acid sequences of SEQ ID NOs: 15, 16, and 17.
7. An isolated antibody or fragment thereof which specifically binds to IGF-1R, wherein the VL of said antibody or fragment thereof comprises the VL-CDR1, VL-CDR2, and VL-CDR3 amino acid sequences of SEQ ID NOs: 79, 80, and 81.
8. A method of producing the antibody or fragment thereof of claim 1 , comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
9. A method of producing the antibody or fragment thereof of claim 2 , comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
10. A method of producing the antibody or fragment thereof of claim 3 , comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
11. A method of producing the antibody or fragment thereof of claim 4 , comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
12. A method of producing the antibody or fragment thereof of claim 5 , comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
13. A method of producing the antibody or fragment thereof of claim 6 , comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
14. A method of producing the antibody or fragment thereof of claim 7 comprising culturing a host cell expressing said antibody or fragment thereof, and recovering said antibody or fragment thereof.
15. An isolated antibody comprising the VH-CDR1, VH-CDR2, VH-CDR3, VL-CDR1, VL-CDR2, and VL-CDR3 amino acid sequences of SEQ ID NOs: 15, 16, 17, 79, 80, and 81.
16. A method of producing the antibody of claim 15 comprising culturing a host cell expressing said antibody and recovering said antibody or fragment thereof.